StockComparison Logo
vs

MTCR vs BCTX

Comparison between Metacrine Inc (MTCR, Company) and BriaCell Therapeutics Corp - New (BCTX, Company).

MTCR vs BCTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
MTCR
$25M
BCTX
$25M
Max Drawdown
Winner
MTCR
97.04%
BCTX
100.00%
Sharpe Ratio
Winner
MTCR
0.62
BCTX
-0.14
5Y Beta
MTCR
N/A
BCTX
0.00
Industry
MTCR
N/A
BCTX
Biotechnology
P/E Ratio
Winner
MTCR
-0.54
BCTX
-0.32
PEG Ratio
MTCR
N/A
BCTX
-0.00
Debt to Equity
MTCR
37.20%
Winner
BCTX
0.00%
P/B Ratio
MTCR
0.67
BCTX
N/A

MTCR vs BCTX - Historical Returns

Returns include dividend reinvestment.

1M
MTCR
+2.43%
Winner
BCTX
+9.68%
3M
Winner
MTCR
+2.41%
BCTX
-15.42%
6M
Winner
MTCR
+39.42%
BCTX
-21.11%
1Y
Winner
MTCR
+17.88%
BCTX
-57.77%
5Y(CAGR)
MTCR
N/A
BCTX
-66.65%
10Y(CAGR)
MTCR
N/A
BCTX
-53.79%
Max(CAGR)
MTCR
-66.40%
Winner
BCTX
-46.06%

MTCR vs BCTX - Annual Returns (2010 - 2026)

Returns include dividend reinvestment.

YearMTCRBCTX
2026N/A-52.58%
2025N/A-91.83%
2024N/A-89.42%
2023+30.13%+27.45%
2022-36.01%-49.83%
2021-91.68%+98.56%
2020-33.16%-53.67%
2019N/A-52.90%
2018N/A-56.25%
2017N/A-33.33%
2016N/A-13.74%
2015N/A+31.36%
2014N/A+115.38%
2013N/A-57.81%
2012N/A-68.61%
2011N/A-63.27%
2010N/A+5.95%

MTCR vs BCTX Drawdown Comparison

The maximum drawdown for MTCR was -97.04%, occurring on Oct 24, 2022. This drawdown has not yet recovered.

The maximum drawdown for BCTX was -100.00%, occurring on Jun 11, 2026. This drawdown has not yet recovered.

The current MTCR drawdown is -95.06%. The current BCTX drawdown is -100.00%.

RankMTCRBCTX
#1-97.04%
Sep 16, 2020 - Oct 24, 2022
-100.00%
May 9, 2011 - Jun 11, 2026
#2N/A-29.21%
Mar 4, 2011 - Apr 28, 2011
#3N/A-27.53%
Oct 28, 2010 - Dec 15, 2010

Correlation

Correlation between MTCR and BCTX is -0.62 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.62
-101

Select Stocks to Compare